News
Blood Test Could Guide Use of Anti-Inflammatory Drug Celecoxib to Reduce Risk of Colon Cancer Recurrence Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer ...
PTOV1 promotes the progression of colorectal cancer. Mechanistically, PTOV1 directly binds to ZNF449, and then the complex synergistically promotes the transcription of MYC. The PTOV1/ZNF449/MYC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback